Vascular Financial Statements From 2010 to 2024
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Check Vascular Biogenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vascular Biogenics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Vascular financial statements analysis is a perfect complement when working with Vascular Biogenics Valuation or Volatility modules.
Vascular |
Vascular Biogenics Company Return On Equity Analysis
Vascular Biogenics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vascular Biogenics Return On Equity | -0.6 |
Most of Vascular Biogenics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vascular Biogenics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Vascular Biogenics has a Return On Equity of -0.5952. This is 97.52% lower than that of the Biotechnology sector and 98.37% lower than that of the Health Care industry. The return on equity for all United States stocks is 92.0% higher than that of the company.
Vascular Biogenics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vascular Biogenics's current stock value. Our valuation model uses many indicators to compare Vascular Biogenics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vascular Biogenics competition to find correlations between indicators driving Vascular Biogenics's intrinsic value. More Info.Vascular Biogenics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Vascular Biogenics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Vascular Biogenics Financial Statements
Vascular Biogenics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Vascular Biogenics investors may analyze each financial statement separately, they are all interrelated. The changes in Vascular Biogenics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Vascular Biogenics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modiin, Israel. Vascular Biogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |